(New York, NY) – December 16th, 2013 – Ai Cure Technologies, an artificial intelligence company providing advanced facial recognition solutions to monitor medication adherence, has been awarded its first issued patent titled “Apparatus and Method for Assisting Monitoring of Medication Adherence” by the United States Patent and Trademark Office. The patent issued on December 10, 2013 as US 8,605,165 and protects Ai Cure’s flagship product AiView®. It is directed to the interactive and automatic guidance system that allows a patient to accurately confirm medication administration with the computer vision system. This patent protects critical elements in Ai Cure’s product lineup and builds upon Ai Cure’s extensive patent portfolio.
The AiView® system has been designed to help patients administer their medication correctly. Detailed interactive audio and visual instructional prompts allow a patient to be trained and guided through any medication administration process in real time in front of a computer or mobile device. Compliance with the interactive guidance also allows for an extremely high degree of robustness and accuracy with the computer vision technology.
Ai Cure has also received a Notice of Allowance on the AiDashboard reporting system for healthcare professionals to manage the data from the AiView system. The patent for this technology will issue in the first quarter of 2014. A number of other patents are expected to issue in 2014 further strengthening Ai Cure’s IP assets.